Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer-Reference-Cited by-同舟云学术

Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer

Published:2006-09-21 Issue:3 Volume:102 Page:375-381
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Bartsch Rupert,Wenzel Catharina,Altorjai Gabriela,Pluschnig Ursula,Bachleitner-Hoffmann Thomas,Locker Gottfried J.,Rudas Margaretha,Mader Robert,Zielinski Christoph C.,Steger Guenther G.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-006-9342-5.pdf

Reference29 articles.

1. Ligibel JA, Winer EP (2002) Trastuzumab/chemotherapy combinations in metastatic breast cancer. Semin Oncol 29:38–43

2. Vogel CL, Franco SX (2003) Clinical experience with trastuzumab (herceptin). Breast J 9:452–462

3. Burstein HJ, Harris LN, Marcom PK et al (2003) Trastuzumab and Vinorelbine as first-line therapy forHer2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm. J␣Clin Oncol 21:2889–2895

4. Slamon DJ, Clark GM, Wong SG et al (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene. Science (Wash. DC) 235:177–182

5. Boss JS, Fletcher JA, Linette GP (2003) The HER-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 8:307–325

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of peroral form of vinorelbine in metastatic breast cancer – choice in favor of quality of life;Medical alphabet;2022-07-26

2. Current regimens for use of vinorelbine in metastatic breast cancer: role and place of oral dosage form, metronome therapy, combinations with anti-HER 2 drugs;Medical alphabet;2020-06-16

3. Therapeutic Efficacy Evaluation of Pegylated Liposome Encapsulated With Vinorelbine Plus 111In Repeated Treatments in Human Colorectal Carcinoma With Multimodalities of Molecular Imaging;Cancer Genomics - Proteomics;2019-12-27

4. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer;Cancer Chemotherapy and Pharmacology;2016-04-08

5. Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series;ISRN Oncology;2014-03-30